Signing an Employment Contract with Precise Biopharma, a Leader in Biopharmaceutical Products.

New Products:
Alyasir Scientific Bureau Signs Contract to Supply Semaglutide

As part of its commitment to providing the latest medical treatments to the Iraqi market, Alyasir Scientific Bureau has announced the signing of a cooperation agreement with a reputable global company to supply Semaglutide. This substance is one of the most significant innovations in the treatment of Type 2 diabetes and weight management, having proven its high efficacy in improving patients’ quality of life.

The product will be available soon in the Iraqi market, making it accessible to all patients in cooperation with accredited medical institutions and pharmacies. This achievement reflects Alyasir Scientific Bureau’s dedication to providing advanced medical solutions that contribute to improving the healthcare sector and serving our community.

Alyasir Scientific Bureau – Your trusted partner in providing outstanding healthcare.